Skip to content

Idexx Laboratories IDXX Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Neogen logo
NeogenNEOG
Zoetis logo
ZoetisZTS
Danaher logo
DanaherDHR
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Agilent Technologies logo
Agilent TechnologiesA
Quest Diagnostics logo
Quest DiagnosticsDGX

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$41.53B+3.7%
Enterprise value$41.9B+3.3%
P/E37.9×-2.7×
P/S9.3×-0.6×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's operating lease right-of-use assets in other assets?
Idexx Laboratories (IDXX) reported operating lease right-of-use assets in other assets of $121.4M in Q1 2026.
How has Idexx Laboratories's operating lease right-of-use assets in other assets changed year-over-year?
Idexx Laboratories's operating lease right-of-use assets in other assets increased by 4.7% year-over-year, from $116M to $121.4M.
What is the long-term trend for Idexx Laboratories's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Idexx Laboratories's operating lease right-of-use assets in other assets has grown at a 6.2% compound annual growth rate (CAGR), from $91.17M to $123.23M.